LCS3 is a reversible and non-competitive synergistic inhibitor of glutathione disulfide reductase (GSR) and thioredoxin reductase 1 (TXNRD1) with IC50s of 3.3 µM and 3.8 µM, respectively. LCS3 has antitumour activity, induces apoptosis and can be used in the study of lung adenocarcinoma (LUAD).
Molekulargewicht:
266.64
Reinheit:
99.84%
CAS Nummer:
[109844-92-0]
Formel:
C11H7ClN2O4
Target-Kategorie:
Apoptosis|||Glutathione reductase
T60446
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten